|
|
Specialty Pharma: Guide to Success at the New FrontierPublished by: Decision Resources Published: May. 31, 2007 - 27 Pages Table of Contents
AbstractRecently catapulted into the pharmaceutical industry limelight, Specialty Pharma may well be the solution to many of Big Pharma’s current woes. Its success driven largely by astute manipulation of the business and market issues that currently plague Big Pharma, Specialty Pharma has shown the potential to capture and firmly command market spaces once dominated by Big Pharma.Get the Answers You Need to Shape Your Strategy The emergence of Specialty Pharma as a market force occurred as Big Pharma and Mid Pharma began to consolidate. What strategies will Specialty Pharma pursue as it continues to capitalize on Big Pharma’s looming market problems? Patents have become a trapdoor for both Big Pharma and Mid Pharma alike; once patents expire, these companies fi nd themselves hanging in a market abyss. What methods are Specialty Pharma using to sidestep such patent expiry pitfalls? What specifi c markets or patient cohorts are receiving attention from Specialty Pharma? Value-for-money is the mantra of today’s knowledgeable and organized health care customers—a challenge for Specialty Pharma, which has received condemnation over its pricing of orphan drugs. How can Specialty Pharma best present its pricing practices to an increasingly informed and skeptical consumer audience? Get Full Details About This Report >> |
|
|||
|
About MarketResearch.com
|
||||